AES Live Event: Straight Talk: The Intersection of Clinician and Patient Perspectives on Cannabinoids
Learn potential mechanisms for cannabinoids, clinical trial updates, and the strategies for communicating risk/benefit to families and caregivers.
Cannabinoids in Epilepsy: New Horizons for Improving the Management of Severe Seizure Disorders
Updates pharmacists on the medical applications of pharmacologic agents derived from cannabidiol (CBD).
Cannabidiol: A Tale of Two Products
An educational program that equips pharmacists with current and useful information regarding cannabidiol.
Cannabinoid Discussion Guide
Know what questions to ask your healthcare practitioners and what to consider when thinking about cannabinoid-based treatments.
Medical Marijuana and Dispensary Products Fact Sheet
Know what the differences are between FDA-approved and non–FDA-approved medications.
The FDA Approval Process
FDA-approved medicines are available by prescription in both specialty and/or retail pharmacies, not dispensaries. Download to learn the difference between FDA-approved and non–FDA approved cannabinoid products.
WHO Recommends CBD Alone Should Not Be a Scheduled Substance
World Health Organization’s (WHO) Expert Committee on Drug Dependence concluded that cannabidiol (in its pure state) does not appear to have abuse potential or cause harm.
Glossary of Cannabinoid Terms
This brochure (developed by Greenwich Biosciences, CEWG, and a patient advocate) offers a quick overview of many of the cannabinoid terms in use today and non–FDA approved medications.
A Disease Awareness Foundation’s Quiz: 10 Things to Know About Medical Cannabis
Test your knowledge of cannabinoids.
Warning Letters Issued by the FDA Regarding Cannabinoid Products
As part of the FDA’s efforts to protect consumers from health fraud, warning letters have been issued to dispensing companies for illegally selling products online that claim to prevent, diagnose,...Read More
Continuing Education on Cannabinoids
Cannabinoid Clinical will only provide links to CME/CE programs from ACCME-accredited providers that are offered with no cost to the viewer. Medscape CME/CE: The Basis of Cannabinoid Therapeutics...Read More
Pharmaceutical-vs-Dispensary-Sourced Cannabinoids: What's the Difference?
An online activity for neurologists, pediatricians, primary care physicians, nurses, and pharmacists interested in increasing their knowledge of how to differentiate pharmaceutical-grade from dispensary-sourced cannabinoids, including...Read More
Health Effects of Cannabis and Cannabinoids Report
The health effects of cannabis and cannabinoids as studied by the National Academies of Sciences, Engineering, and Medicine’s expert committee.
Handbook of Cannabis by Roger Pertwee
A 700+ page book by leading researchers from around the world, covering history, pharmacology, potential therapeutic uses, and clinical research of cannabinoids.
JAMA: Labeling Accuracy of Cannabidiol Extracts
The Journal of the American Medical Association (JAMA) published research letters on the labeling accuracy of products sold in dispensaries, online, or in brick-and-mortar shops.
Current Cannabis Controversies
A review of issues facing cannabinoid medicine and research by Ethan B. Russo published in Frontiers in Pharmacology.
Does the Passage of the 2018 Farm Bill Legalize Non–FDA Approved Hemp-Derived Cannabinoid Products?
It is not fully clear when hemp-derived cannabinoid products will be federally legal to be sold or how they will be regulated.
Importance of Monitoring Drug Interactions Between Medications and Cannabinoid Products
Based on the 4 FDA-approved cannabinoid drugs, these posters provide a quick overview, for the pharmacist and the patient, of possible drug interactions between medications and cannabis products along with possible side effects.
The information is brought to you by Greenwich Biosciences in partnership with the American College of the Apothecaries and Pharmacists Planning Services Inc.